Fred Hutchinson Cancer Center is an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care, research and learning. The first National Cancer Institute-designated cancer center in the Pacific Northwest, Fred Hutch’s global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy, and COVID-19 vaccines has confirmed our reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
The Health and Behavioral Innovations in Technology (HABIT) Group, led by Dr. Jonathan Bricker, is part of the Cancer Prevention Program in the Division of Public Health Sciences at the Fred Hutchinson. Funded by multiple large NIH grants ($25 million USD cumulative total to date), the Group’s research mission is to develop and rigorously test behavioral interventions for health behavior change, and disseminate them with the goal of high public health impact.) Our group is now conducting several clinical trials to test a newer form of therapy, called Acceptance & Commitment Therapy, to help people lose weight or quit smoking.
We are seeking a counselor who is passionate about clinical work and wants to help science make the next breakthroughs in health behavior change. This is an exciting opportunity to learn and conduct a newer therapy called Acceptance & Commitment Therapy (ACT) as part of a NIH-funded clinical trial to test its effectiveness as an intervention to increase healthy eating and exercise. This is a 0.8 to 1.0 FTE position (32 – 40 hours per week). The counselor will have a caseload of participants and provide individual sessions of ACT therapy and standard behavioral therapy for weight loss over the telephone. We will provide training and ongoing supervision in this new treatment program and in behavioral therapy for weight loss. The position provides competitive pay, flexible hours, and the opportunity to work with supportive and highly skilled team of clinicians, researchers, and support staff.
Required Qualifications:
Preferred Qualifications:
Fred Hutch has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations.
As a condition of employment, newly hired employees must provide proof of vaccination or initiate the accommodations process before their first day of employment.
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through your work at Fred Hutch is requested of all finalists.
Fred Hutchinson Cancer Center is an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care, research and learning. The first National Cancer Institute-designated cancer center in the Pacific Northwest, Fred Hutch’s global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy, and COVID-19 vaccines has confirmed our reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
The Health and Behavioral Innovations in Technology (HABIT) Group, led by Dr. Jonathan Bricker, is part of the Cancer Prevention Program in the Division of Public Health Sciences at the Fred Hutchinson. Funded by multiple large R01-level NIH grants from the NCI and NIDDK ($25 million USD cumulative total to date), the Group’s research mission is to develop and rigorously test behavioral interventions for tobacco cessation and weight loss health and disseminate them with the goal of high public health impact. Technologies for delivering these interventions include smartphone applications, chatbots, websites, and telephone counseling. One of the behavioral approaches the Group has been testing is called Acceptance & Commitment Therapy (ACT). The HABIT Group is committed to increasing the diversity of future scientists passionate about research devoted to scaling behavioral principles for public health impact.
Under the mentorship of Dr. Bricker, a Full Professor, and one of the HABIT Group’s Staff Scientists, Dr. Margarita Santiago-Torres, the Post-Doctoral Research Fellow will lead and co-author multiple scientific research papers and conduct original research that is part of the ongoing research from any one of our three current NIH R01 Phase III clinical trials. Regarding scientific research papers, the Fellow will be mentored in writing papers and presenting results at scientific national and international conferences. The Fellow will have access to existing data from large, randomized NIH R01 Phase III trials on tobacco cessation conducted by the HABIT Group. Existing data will include the recently published iCanQuit study (JAMA IM, 2020) of a smartphone application proven efficacious for smoking cessation. The Fellow with receive full support from the HABIT Group’s biostatistician as well as training in clinical trial design, analyses of outcomes and mechanisms of action. The HABIT Group’s administrators will provide support for manuscript preparation and submission.
Regarding conduct of original research, the Fellow will be mentored in proposing a 2 to 3 year NIH Diversity Supplement grant (NCI or NIDDK) for a research project that will be an integral part of the ongoing research of one of our three current R01 Phase III clinical trials. A Diversity Supplement grant will contribute significantly to the health research career development of the Fellow. The Group’s three NIH R01 Phase III current trials focus on testing the efficacy of (1) an artificial intelligence chatbot for cigarette smoking cessation, (2) a smartphone application to help cancer patients stop cigarette smoking, and (3) telephone coach-delivered Acceptance and Commitment Therapy for weight loss. The Fellow will receive ongoing mentoring in the Diversity Supplement research project, interact with the Group and collaborators on the selected clinical trial, contribute intellectually to the research, and enhance research skills and knowledge in tobacco cessation, obesity, behavioral science, and delivery of digital interventions.
Summary of Responsibilities:
To be considered, the successful candidate must:
Fred Hutch has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations.
As a condition of employment, newly hired employees must provide proof of vaccination or initiate the accommodations process before their first day of employment.
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and anti-racism in your career or that will be made through your work at Fred Hutch is requested of all finalists. #ZR
Fred Hutchinson Cancer Center is an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care, research and learning. The first National Cancer Institute-designated cancer center in the Pacific Northwest, Fred Hutch’s global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy, and COVID-19 vaccines has confirmed our reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
Applicants from backgrounds traditionally underrepresented in scientific disciplines are particularly encouraged to apply.
The Fred Hutchinson Cancer Research Center has a 2-year Postdoctoral Position available through the Cancer Prevention Department. Specifically, this position is under the direction of Dr. Vida Henderson within the Division of Public Health Sciences at Fred Hutch. Dr. Henderson’s research aims to improve gender and racial health inequities by exploring multi-level barriers to cancer care and service utilization and developing and testing interventions to overcome these barriers, with the overarching goal of increasing health equity. Most of her work focuses cancer disparities and inequities, minority health, breast cancer disparities, women’s health, health communication, health services utilization, and community-engaged research. Dr. Henderson’s research uses diverse methods of qualitative and mixed methods research methodology as well as program evaluation, implementation, and dissemination science.
Fred Hutch provides a highly interactive and supportive environment for junior investigators to grow and develop their future careers; it consistently ranks in the top 20 best places to work for postdocs, as surveyed by The Scientist.
The postdoctoral fellow’s duties will allow participation along the entire research continuum, from study development to dissemination of results. They will work closely with Dr. Henderson and research collaborators based both locally and nationally. They will have the opportunity to participate in studies funded through multiple mechanisms (private foundation, federal grants, and non-sponsored internal funding). The post-doc will have access to diverse types of data, available for cutting-edge hypothesis testing and development and team collaborations. There are opportunities to work on existing projects and to develop new projects addressing relevant research topics.
Responsibilities include:
In addition to possessing the above qualifications, the ideal candidate will also posses the following characteristics:
Fred Hutch has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations.
As a condition of employment, newly hired employees must provide proof of vaccination or initiate the accommodations process before their first day of employment.
Please include a Diversity, Equity, and Inclusion statement and cover letter detailing your research interest and suitability for this position with your application.
Fred Hutchinson Cancer Center is an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care, research and learning. The first National Cancer Institute-designated cancer center in the Pacific Northwest, Fred Hutch’s global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy, and COVID-19 vaccines has confirmed our reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures for the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
A Clinical Research Division laboratory that studies the biology of blood and marrow stem cells and develops novel stem cell gene therapies as well as genome editing technologies is recruiting a Research Technician II to assist with development and production of novel gene transfer vectors and performing associated QC assays. Duties may include performing molecular cloning, PCR, QPCR, ELISA, processing and analysis of samples for flow cytometry, sterile cell culture work with cell lines and primary cells.
The position involves additional responsibilities, such as analysis of data using software like Prism and Snapgene. The candidate should be motivated to participate in sample processing and analysis from preclinical modeling experiments. This position affords the motivated technician an opportunity to develop/utilize cell culture and molecular biology skills, and latest genome editing platforms.
Fred Hutch has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations.
As a condition of employment, newly hired employees must provide proof of vaccination or initiate the accommodations process before their first day of employment.
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through your work at Fred Hutch is requested of all finalists.
Your search for "" did not match any of our available careers. Please try another search term or combination of terms and filters.